Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice

Regionshospitalet Viborg, Skive

Status: Completed

Conditions: Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease

Treatments: Biological: infliximab and adalimumab

Study type: Observational

Funder types: Other

Identifiers

NCT02322008

Anti-TNF, IBD

Details and patient eligibility

About

Can genetic markers be used to predict anti-TNF response? A cohort was established to identify SNPs associated with anti-TNF therapy in patients with inflammatory bowel disease.

Enrollment: 1,035 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CD or UC, treated with anti-TNF

Exclusion criteria

• Missing data